Duke Specialized Program in Research Excellence (SPORE) in Brain Cancer Career Enhancement Program

Funding Agency:
Duke University

The National Cancer Institute-funded SPORE in Brain Cancer at Duke University is requesting applications for
pilot projects from new and early stage investigators with translational1 potential for funding through the SPORE
Career Enhancement Program (CEP).

The CEP of the Duke University SPORE in Brain Cancer supports promising individual or collaborative pilot
research projects that have a translational potential and are likely to generate new knowledge with a high
probability to impact the diagnosis, treatment and/or prevention of adult and/or pediatric brain tumors. In
accordance with NIH provisions, all funded CEP projects that have strong translational potential may become
full projects in the SPORE. Although both clinical and laboratory research projects are eligible for funding, the
translational emphasis of the program requires that the hypotheses in all projects have the potential to impact
the incidence and mortality of brain cancer or improve the quality of life for brain cancer patients. These projects,
however, do not have to reach a human endpoint during the project period, but should, ideally, utilize human
cells or tissues, and/or, have the potential to translate to the human context. The resources of the Duke SPORE
in Brain Cancer, including the SPORE Biospecimen, Pathology, and Immune Monitoring Core, are available to
all investigators and those interested in utilizing these resources should consult with the appropriate Core
leaders. Innovative projects are encouraged. We particularly wish to encourage women and minority
investigators, investigators from minority and other area institutions, as well as individuals who have not
previously worked in the brain tumor field to apply. Applications for scientific teams and scientists exploring new
areas of investigation are encouraged. Duke is an equal-opportunity employer, and we value diversity in all of its
many facets and meanings.

Stage 1 deadline for all applications is by noon on June 11, 2021

Full RFA

Agency Website

Eligibility Requirements

This program typically supports junior faculty or established investigators who wish to further develop or refocus
their careers on translational research in brain cancer. This program does not support pre- or post-doctoral
fellows, either preclinical or clinical. However, advanced post-doctoral or clinical fellows who provide a letter from
an institution stating that the candidate will be joining its faculty within the year are eligible for this program.
Investigators supported by NCI career development awards (K series) may also be eligible for support through
this program. An applicant should not have previously received funding through the Duke Brain SPORE CEP.



Amount Description

Funding decisions will be made in August and communicated directly to the PI. Successful projects will be funded
September 1, 2021 - August 31, 2021, at a maximum of $100,000 per year, renewable for a second year.

Funding Type



Junior Faculty
Women and minorities encouraged


Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

June 11, 2021